About Us
About us
Our Story
Founded in 1988 by the Late Dr. Muhammed Majeed, an internationally acclaimed scientist and entrepreneur in the area of “Evidence Based Medicine”, Sabinsa is a research-driven multinational health science company. We are leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, and biotics for the nutritional, cosmetic, pharmaceutical and food industries.
Sabinsa has carved a niche for itself by its extensive research support for its customers and products, and the scientific credentials of its technical staff.
Sabinsa’s efforts have begun to earn the company vast recognition, in addition to growing sales.

Mission & Vision
We envision a world where nature-inspired wellness is accessible through trusted, ethically sourced ingredients and cuttingedge research. Sabinsa is committed to innovation through research, ensuring our products are safe, effective, and backed by clinical studies–bridging tradition with science.
The company has pioneered sustainable practices with its farmers and implemented solar capabilities at some of its centers to become a global leader in nutraceuticals and cosmeceuticals markets by providing science-based solutions that empower healthier lives.
Our Milestones
Our Legacy of Progress and Innovation
2023
- Industry Outlook names Sami-Sabinsa Group as one of the "Top 10 Food Ingredient & Additive Manufacturers" for 2023
- Sabinsa Celebrates 35th Anniversary
- Sabinsa Opens Office in France, Appoints Ms. Nathalie Allaume as Sales Manager
- Sabinsa Nanjing wins ‘2023 Technology Innovation Award’ for LactoSpore®
- Sabinsa Corporation honored with “Varro E. Tyler Commercial Investment in Phytomedicinal Research” Award
- Sami-Sabinsa Group Commits to Clean, Renewable Energy : Captive solar energy will power five manufacturing plants
- Sabinsa Reaches Intellectual Property Milestone with Over 400 Granted Patents
2022
- Sami-Sabinsa Group Releases Book on “Selenium in Health and Diseases”
- Sami-Sabinsa honoured with “Best Manufacturer Export Award 2022” by FKCCI
- Sami-Sabinsa Group has been ranked as one of the Top 10 Pharma Laboratories in the year 2022 by India Pharma Outlook
- Dr. Muhammed Majeed, Chairman and Founder of Sami-Sabinsa Group, was named the “Legend of the Millennium in Nutraceutical Industry” by ASSOCHAM for his outstanding contributions to the field of nutraceuticals.
- In conjunction with the Global Ayush Investment & Innovation Summit 2022, Sami-Sabinsa signed a MoU with the farmers of J&K through the J&K Medicinal Plants Board.
- Sami-Sabinsa Group signed a historic MoU with Manav Sadhan Vikas Sanstha (MSVS) for the cultivation of Garcinia indica plant used for the production of Livinol®.
- Sami-Sabinsa Group attended the Joint Parliamentary Committee meeting on the Biological Diversity (Amendment) Bill, 2021 to discuss the impact of the amendment on the Nutraceutical Industry and possible ways forward.
- Sabinsa has received Novel Food approval from the European Food Safety Authority (EFSA) for its patented Curcumin C3 Reduct®.
- Sabinsa receives TGA Approval for use of LactoSpore® as listed medicine in Australia.
- Sami-Sabinsa accomplishes Intellectual Property Milestone with over 400 plus Granted Patents (as of Dec 2022)
- Sabinsa’s Cirpusins® shows effective management of obesity and lipid levels in a published study.
- Indian Customs grants Sami-Sabinsa Group the Authorized Economic Operator (AEO) Tier–Two Certificate.
- To support various CSR initiatives, Dr. Majeed Foundation contributed Rs. 4.88 Crores during the Financial Year 2021-2022.
2021
- Sabinsa’s Postbiotic LactoSporin® Wins 1st Place in NIE Awards
- Sami-Sabinsa Names Dr. Umar Jan as President of European Operations
- Sabinsa expands UK and EU footprint with new staff
- Sabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted
- Sabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber
- Research Published on Sabinsa’s Curcumin C3 Complex® / BioPerine® Combination as Adjuvant Therapy in COVID-19 Patients
- Court Orders Prakruti to Pay over $1 Million in Fees and Costs to Sabinsa as a Sanction for Discovery Abuses in Litigation
- Sabinsa Founder Dr. Muhammed Majeed Named Father of Indian Nutraceuticals Industry by ASSOCHAM
- New Research Published on Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient
- Sabinsa Top Scientist Gives Presentation to U.S. FDA
2020
- Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM
- Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study
- Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement
- Sabinsa Founder Dr. Muhammed Majeed Publishes Fourth Book on Boswellia
- Sabinsa Continues the Fight Against Adulterated Vitamin C in Food and Beverage Products by Alerting Regulatory Agencies
- Sabinsa Providing Glyphosate Test Results with Ingredients
- Sabinsa Granted Patent in Mexico on Boswellin® PS for Inflammation
- Sabinsa Granted Three New Patents in Canada, Including uC3 Clear® Water Soluble Curcumin
- Dr. Majeed Foundation Distributes 5,500 Rice Bags to Needy Communities in Karnataka, India
- Sabinsa Granted Patent on a Combination of the Company’s Ingredients for Hair Growth in Mexico
- Sabinsa Publishes Study Evaluating Hair Health Serum in Trial of Adults Hair Thinning and Loss
- Research on Sabinsa’s Cosmeceutical LactoSporin® Showing Anti-Acne Benefits Among the First Published Human Clinical Studies Examining a Probiotic Metabolite
- Sabinsa Issues Cease & Desist Letter Regarding Mischaracterized Amla Extracts to Applied Food Sciences
- Sabinsa Introduces LivLonga®, a New Patented Combination for Liver Support
- Sabinsa Earns Non-GMO Project Verification for Eleven Key Ingredients
- Sabinsa’s Curcumin C3 Complex® with BioPerine® Shown to Improve Cytokine Level
- Dr. Majeed Foundation Makes Significant Contributions to Combat COVID-19 in India, Including $1.32 Million to PM CARES Fund
- Sabinsa Warns Industry Against Mischaracterized Amla Extracts
- Research Review of Curcumin’s Immune Benefits by Sabinsa Founder Dr. Muhammed Majeed Published
- Sabinsa’s pTeroWhite® Subject of Two New Published Studies Reporting Anti-Aging, Skin Brightening, and SPF Benefits
- Sami-Sabinsa Group Celebrates Three Prestigious Awards From ASSOCHAM
- Sabinsa to Feature Dispersible Curcumin and Functional GRAS Ingredients at Expo West
- Sabinsa’s Parent Company Sami Labs Breaks Ground on $30 Million USD State-of-the-Art Production Facility in India
2019
- Sabinsa Named a Top New Jersey Company for Its Dynamic Growth
- Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming Ability to Reverse Depression Symptoms in Patients Suffering from IBS
- Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study
- Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company
- Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence
- Research Finds Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® Effective for Non-Alcoholic Fatty Liver Disease
- Sami-Sabinsa Honored with Multiple “Best of” Awards in New Delhi and Singapore
- Sabinsa Founder Dr. Muhammed Majeed Publishes Book on Reductive Metabolites of Curcuminoids
- Sabinsa to Feature Tinofolin® Nootropic, Livinol™ for Liver Health & Weight Control, and Starmeric™ Turmeric-Derived Prebiotic at Supplyside West
- Pilot Study Published Examining Curcumin C3 Complex® and BioPerine® With Taurine as Treatment for Hepatocellular Carcinoma
- Study Shows Inhibitory Effect of Curcumin Curcumin C3 Complex® and BioPerine® Combination on Malignant Mesothelioma Cells
- Sabinsa Opens Sales Office in Poland to Serve Eastern Europe
- Sabinsa’s Four Indian Manufacturing Sites Achieve FSSC 22000 Certification
- New Research Expands upon Use of Sabinsa’s Curcumin C3 Complex® as an Adjunct to Chemotherapy
- Sabinsa’s Curcumin C3 Reduct® Self-Affirmed GRAS
- Sabinsa Achieves USP GMP Audited Status for Three Additional Sites
- Published Study Reaffirms Function and Survival of Sabinsa’s LactoSpore®
- Sabinsa Shagandha™ Ashwagandha Root Extract 2.5% Designed to Meet USP Monograph, Verified by Prominent Botanical Testing Expert Alkemist Labs
- Sabinsa Scientist Dr. Natarajan honored by IASTAM for Nutraceutical Product Development
- Sabinsa Launches LactoSporin®: Novel Probiotic Metabolite For Skin and Hair
- Sabinsa Awarded New Patents for ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
- Sabinsa’s Biotechnology Site Achieves USP GMP Audited Status
- Sabinsa’s Manufacturing Arm Receives Research Funding From The Government of India
- Published Analysis of Curcumin Research Provides Comprehensive Overview
2018
- Sami–Sabinsa Founder and Sami Labs Honored With Multiple Awards by Associated Chambers of Commerce & Industry of India for Outstanding Nutraceuticals Industry Achievement
- Research on Curcumin’s Positive Effects on Microbiome Published Sabinsa Supplied Curcumin C3 Complex® and BioPerine® to Researchers
- Sami-Sabinsa Group Diversifies into Information Technology and Business Solutions With Expansion of Edkal Technologies to US
- Sami-Sabinsa Honored By Pharmexcil For Export Excellence
- Sabinsa’s Shelf Stable Probiotic LactoSpore® May Improve Cholesterol Levels, Study Suggests
- Sami–Sabinsa Honored by Associated Chambers of Commerce & Industry of India for Beauty, Wellness & Personal Care
- Sabinsa’s Nigellin™ Black Cumin Seed Extract Identified as a Potent Favorable Immunomodulation in Asthma Inflammation
- Sabinsa Signs Memorandum of Understanding with Japan External Trade Organization at Summit With Prime Ministers of India and Japan
- Sabinsa Opens Toronto Office to Support Canadian Customers and Market
- Sami-Sabinsa Group FSMA Implementation Update: 14 Staff PCQI Certified
- Sabinsa Honored with Two Prestigious Awards Acknowledging the Significance of the Company’s Cultivation and Reforestation Programs
- Sami-Sabinsa Group Scientists Publish Research on Flow Cytometry as an Effective Test Method to Assess Viable Spore Count in LactoSpore®
- Sami-Sabinsa Group Acquires Exclusive Global Marketing Rights for European and USA Patents on Oroxylum indicum
- Sami-Sabinsa’s Pterocarpus marsupium Reforestation Program Named Industry Initiative of The Year Award Finalist
- Sami-Sabinsa Recognized For Export Achievement by Federation of Karnataka Chambers of Commerce & Industry
- Sabinsa’s Legal Victory Over Olive Lifesciences for Patent Infringement Profiled in Prominent Law Journal
- Sami Labs – Sabinsa Hyderabad Facility Receives NSF GMP Certification
- Sami-Sabinsa Founder Dr. Muhammed Majeed named NutraChampion
- Sabinsa parent company Sami Labs honored with outstanding export award
- Sabinsa successfully protects its Curcumin C3 Reduct® technology
- Tufts – Tohoku study on curcumin + piperine combination verifies Sabinsa’s research on synergistic properties
- Sabinsa announces 10 year reforestation commitment to Pterocarpus marsupium cultivation
- Sabinsa and Eurofins enter into global ID testing agreement for proprietary ingredient
2017
- New patents granted to Sabinsa’s cosmetics division in US and EU
- Sabinsa granted US patent for synbiotic composition of LactoSpore® shelf stable probiotic and cranberry fibers
- Sabinsa publishes scientific compendium on BioPerine® black pepper extract
- Shaheen Majeed named Sabinsa President worldwide
- Sabinsa successfully protects its Curcumin C3 Reduct® technology
- Sabinsa’s Curcumin C3 Complex® with BioPerine® shows protective role in lipid profile modification in type 2 diabetes in published study
- Court orders olive lifesciences to pay sabinsa $2.2 million for willfull infringement
- Sabinsa granted US patent on LactoSpore® for IBS
- Sabinsa’s Curcumin C3 Complex® studied for antioxidant effect in diabetes patients
- Sabinsa’s DigeZyme® shows benefit for delayed onset muscle soreness in published study
2016
- Sabinsa’s Boswellin® super reported In japanese study to show improvement in knee pain
- European journal publishes article on Sami / Sabinsa oil control moisturizer safety and efficacy
- Nachurel ingredients agrees to consent judgment honoring Sabinsa’s Tetrahydrocurcuminoids patent
- Sabinsa’s Curcumin C3 Complex® in combination with Omega-3s found to have synergistic effect
- Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports
- Sabinsa receives approval for New Health Claims on Curcumin C3 Complex® and Curcumin C3 Reduct® in Canada
- Sabinsa successfully defended its proprietary rights for “Boswellin”
- Sabinsa achieves significant canadian health claim on IBS for shelf-stable probiotic LactoSpore®
- Sami-Sabinsa recognized by global health & pharma as the best international life science company and most innovative inflammatory condition treatment
- Sabinsa’s parent company Sami Labs recognized for excellence in research and development
- Sabinsa / Sami Labs recognized for export excellence by Karnataka government trade promotion center
- New safety, stability and efficacy studies published on Sabinsa’s GRAS, shelf-stable probiotic LactoSpore®
- Sabinsa defends Tetrahydrocurcuminoids patent with legal action
- A clinical study by the university of georgia found that Resveratrol fortified with Sabinsa’s BioPerine® increases mitochondrial function
- Sabinsa announces curcumin testing program to assure authenticity in campaign to eliminate adulteration with synthetics
- Metabolic syndrome study on Sabinsa’s Curcumin C3 Complex® honored with university research of the year award
- Sabinsa receives "no questions” letter from the us FDA on GRAS status for LactoSpore®
- Muhammed Majeed, Ph.D. honored as industry legend and inducted into the Hall of Legends at Natural Products Expo West, 2016
- Dr. Majeed, Sabinsa’s founder, honored with Global Innovation & Excellence Award for 110 patents, and recently added 15 new patents
- Stability research published on Sabinsa’s LactoSpore® shelf stable probiotic for functional foods
- Cumulative safety data of ForsLean®, the company’s patented coleus forskohlii extract, published in an International Scientific Journal
2015
- Sabinsa’s LactoSpore® Human Safety Study Cleared For Health Canada Access
- Sabinsa Patent Infringement Litigation Against Prakruti Settled: Curcumin C3 Complex® Patent Successfully Defended
- Sabinsa Launches New, Nano-Free Water Soluble Curcumin Form: uC3 Clear™
- Sami Labs Recognized With Two State Export Excellence Awards By Visvesvaraya Trade Promotion Centre, Karnataka, India
- Sabinsa once more successfully protects Curcumin C3 Complex® patent infringement litigation against Herbakraft settled
- Sabinsa Awarded Four New Us Patents: Patent Portfolio Total Climbs To 95
- Sabinsa expands herb cultivation program founder promotes sustainability, advocates cultivation to protect India’s herbal legacy
- Sabinsa’s Curcumin C3 Complex® Shows Significant Benefits in Lipid Levels in Patients With Coronary Artery Disease
- UK Study Shows Sabinsa’s Curcumin C3 Complex® to Be Safe Adjunct to, and Enhance Efficacy of, Folfox Chemotherapy
- Sabinsa / Sami Labs Recognized With Award For Export Excellence By Karnataka Chamber of Commerce
- Sabinsa’s Utah Facility Receives Foreign Site Registration Number From Canada
- Shaheen Majeed Appointed To Sami Labs Group Board Of Directors
- Sabinsa again honored with two pharmexcil awards noting excellence in patents and exports
- Curry Powder To Clinical Significance: New book provides a comprehensive understanding of curcumin & studies on Curcumin C3 Complex®
- Sabinsa Victorious In Litigation Against Nutribiolink For Curcumin C3 Complex® Patent Infringement
2014
- Sabinsa adds four new patents, bringing world wide portfolio to 91
- C3 Reduct® wins Functional Ingredients editors choice award for best science
- Sami and Sabinsa receive Best New Product Excellence Award in the raw material category at Panacea-Natural roduct Expo India for Saberry®
- Sabinsa / Sami Labs entered into a Memorandum of Understanding with India’s Ayurvedic research organization, Arya Vaidya Sala, Kottakkal (AVS)
- Sabinsa / Sami Labs receives two pharmexcil awards for 2012 – 2013 in the herbals, ayurveda & nutraceuticals category: The gold award for patents and the silver award for exports in herbals
- Former President of India visits Sami Labs (late A.P.J. Abdul Kalam)
- Sabinsa introduces new form of coleus with ForsLean® Soft Extract
- Study shows Boswellia® cream may provide relief for psoriasis
- Sabinsa initiates lawsuit against four companies for Curcumin C3 Complex® patent infringement
- Iranian clinical study shows combination of C3 Complex® and BioPerine® offer relief for osteoarthritis patients
- Sabinsa Launches Animal Nutrition Division: Vetvitals®
- Sabinsa’s Curcumin C3 Complex® and BioPerine® combination used in metabolic syndrome study
- Sabinsa/Sami Labs acquires KCP Biotech, expands capacity and adds more colors
- Sabinsa teams up with Fruit D’Or to launch LactoSpore®-Cranberry combination LactoCran™
- Sabinsa’s LactoSpore® moves into cosmeceuticals with topical Candida products
2013
- Next generation of curcumin launched, resolving potency, color, dosage, stability and bioavailability concerns, called Curcumin C3 Reduct®
- Recipient of Frost & Sullivan’s 2013 North American Integrated Prebiotic Delivery Technology Innovation Award
- United States patent granted on a unique weight management formula
- United States patent granted for a natural preservative, SabiLize®
- Sabinsa Utah Facility Earns NSF Good Manufacturing Practices (GMP) Registration
- Sabinsa on Wheels returns to USA, three major states selected and presented at Utah, California, and New Jersey
- Sabinsa’s Curcumin Receives GRAS No Comment Letter From FDA
- Sabinsa's Sami Labs named product Innovator Of The Year
- Sabinsa’s LactoSpore® Inspires Gluten-Free Expert To Create Gourmet Cookies
- Sabinsa Launches D’Cosmix Range Of Dermaceutical Composites At International Exhibitions
- Sabinsa Breaks Ground On Additional Facility, Increasing Production 200%
2012
- Curcumin C3 Complex® wins Functional Ingredients editor's choice award in the marketing category
- Sabinsa’s LactoSpore® Chosen For Tutti Frutti, World’s Top Selling Self-Serve Frozen Yogurt
- The first non-diary use of Sabinsa’s Shelf-Stable Probiotic, LactoSpore®, can be found in Colombia’s Perman Bread
- New Study says Sabinsa's Curcumin C3 Complex® shows significant reduction in Serum Triglycerides
- Sabinsa Publishes Book on Tetrahydrocurcuminoids
- Sabinsa on Wheels held for the first time in Seoul, South Korea
- Sabinsa wins patent in Japan for coleus derived Glaucoma Treatment product
2011
- Sami Labs inks Research Collaboration Agreement with National Institute of Medicinal Materials (NIMM), Ministry of Health, Vietnam for Research & Development of Vietnamese Traditional Medicinal Plants
- Sabinsa Introduces Integrated Nutritional Composites™ (Inc) Bilayered Tablets
- Sabinsa’s BioPerine® Validated In Resveratrol Pre-Clinical Study
- Sabinsa Global Expansion Continues: Opens Offices In Korea
- Sabinsa Receives Top Pharmexcil Award
- Sabinsa R&D Named Best Innovation And Technology Company
2010
- Sami's Kunigal plant near Bangalore, India received NSF (National Sanitation Foundation) GMP certification
- Received the first patent in China for "Process For Preparing Water Soluble Diterpenes And Their Applications"
- Sami Labs inks an agreement with CIPLA to market its drug, Sornip for Psoriasis in Indian market
- Sami's Kunigal plant near Bangalore, India received Bureau Veritas ISO 22000 Certification
2009
- Sabinsa received the 2009 Herbal Industry Leader Award from the American Herbal Products Association
- Sabinsa received its 57th patent and it is the first patent from Russia
2008
- NABL accreditation for laboratories of Sami Labs Limited
- Continuous Extraction plant commissioned by Sami Labs Limited in Bangalore
2007
- Sabinsa sets up its office in South Africa
2006
- Forskolin Eye Drops approved by DCGI for Glaucoma
- Sabinsa Europe GmBH was set up in Langen, near Frankfurt in Germany
2005
- Received two patents for Tetrahydropiperine
- Received the second Thomas Alva Edison Patent Award for 2005
2004
- Sabinsa's US Patent for ForsLean® received the Thomas Alva Edison Patent Award for 2004
- Dr. Majeed was conferred the Ellis Island Medal of Honor by the National Ethnic Coalition of Organizations (NECO)
2003
- MGP Herbal (P) Ltd was acquired to facilitate and co-ordinate Herbal Cultivation - a major step that helped provide jobs to several farmers in India
2002
- Super-Critical Fluid Extraction facility set up at Nelamangala
- The R & D Centre of Sami Labs Limited, Bangalore received the DSIR Award for its R & D efforts
2001
- The anti-obesity product Forslean® was voted as the Best New Product of the year by Nutraceutical Industry Association – Nutracon in the US
- Sabinsa received its first European patent on Curcuminoids
- Sabinsa Japan Corporation was started
2000
- Biotechnology Center established at Nelamangala, Bangalore
- Tetrahydrocurcuminoids, also referred to as “White Curcumin” was introduced as a skin lightener into the US market
1998
- Sami Chemicals and Extract Pvt. Ltd. – name was changed to Sami Labs Limited to reflect more accurately its current activities
1997
- New Jersey Technology Fast 50 Award
- Sabinsa listed again in the Inc 500 companies, ranking # 90
- Award for Export Performance for Spice products from President of India
1996
- Sabinsa was listed in the Inc 500 companies, ranking # 70
- First US patent awarded for the product BioPerine® was awarded to Sabinsa Corporation
- An Export-Oriented manufacturing unit is established at Kunigal, Bangalore
1993 – 95
- Standardization of Indian herbal medicines by Sami research group
- Sabinsa started the “Sabinsa on Wheels” program also know as SOW. Here the Sabinsa team endeavors to share its knowledge to a large group of professionals and common man on its diverse range of products
1991
- Sami Chemicals and Extracts Pvt Ltd set up in Bangalore
1988
- Sabinsa Corporation, New Jersey USA was setup
What We Do
Sabinsa, a pioneer and global leader in health science, is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, biotics, and enzymes.
The company’s corporate R&D encompasses independent research divisions, including Natural Drugs, Phytochemistry, Synthetic Chemistry, Tissue Culture, Biotechnology, Analytical R&D, Biological Research, Microbiology, and Formulation R&D. These divisions collaborate in a synergistic work model to produce products that adhere to international standards.
With the collective wisdom of over 120 research scientists, Sami-Sabinsa Group has developed standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe
Innovative Nutritional Ingredients Backed by Science
At Sabinsa, we specialize in developing and manufacturing high-quality nutraceutical ingredients rooted in the
Science-Driven Beauty with Ayurvedic Roots
Sabinsa’s cosmeceutical ingredients bridge the gap between traditional beauty rituals and cutting-edge
Sustainable, Trusted and Ethical
Sabinsa’s commitment to sustainability and ingredient quality begins at the source. Our robust contract farming program ensures a consistent, high
Manufacturing Facilities
Sami-Sabinsa Group manufactures its products utilizing global standards global standard at its state-of-the-art manufacturing facilities located in Bengaluru, Hyderabad (India), and Utah (USA).
This facility is designed and equipped with fermentation tanks to produce probiotics and enzyme blends.
A unique facility with a continuous extractor made entirely of Stainless Steel 316, more than 40 tonnes of herbal raw material can be extracted in a day.
A recent addition to our several manufacturing facilities, it has the capability to process and manufacture multiple products of both synthetic and natural origin.
One of the major manufacturing facilities of the group is situated here. With well developed and segregated blocks, this facility has the capability to process several tonnes of extract and manufacture multiple products of both synthetic and natural origin.
This facility at Utah provides a strong formulation support and is equipped to handle various dosage forms. The stick pack facility offers convenient package form for the growing industry needs.
The state-of-the-art greenfield facility has adopted the best-in-class technologies for the manufacture of Synthetic Active Nutraceutical Ingredients (ANI) and Active Pharmaceutical Ingredients (API) for the global market.
This facility is the first of its kind wherein the Industry and Academia have collaborated to develop it commercially.
A state-of-the-art facility that adapts a new technology, wherein carbon dioxide is used as the extraction solvent. As eco-friendly technology, it provides both the manufacturer and the end user a clean extract with an almost intact bio-potency.
Our People
Intellectual Properties
Sabinsa has a strong intellectual property portfolio and has received over 510 global patents with 290 more pending worldwide.

510+
Total Number of Patents
26+
Total Number of Countries
120+
Total Number of Products
Recognitions
Since its inception Sabinsa has been consistently honored throughout the years with numerous accolades and awards for its science and technological advancements within the nutrition, cosmetics, and pharmaceuticals industries.